COVID-19 is the illness thats caused by the novel coronavirus SARS-CoV-2. To date, the Food and Drug Administration (FDA) has provided emergency use authorization to three different vaccines to help protect against COVID-19:
Read on to learn how each vaccine works, how safe and effective each one is, and how to decide which one may be the right choice for you.
The vaccines that have been authorized for emergency use in the United States so far use two different types of technology:
Lets break down how each vaccine uses one of these two technologies to help promote immunity against the coronavirus. Check out the infographic below to see a visual representation of how the mRNA and adenovirus vector vaccines work.
The Pfizer-BioNTech vaccine is also called BNT162b2 in the scientific literature and Comirnaty in some countries. Its given in two doses spaced 21 days (3 weeks) apart.
The Pfizer-BioNTech vaccine uses mRNA technology, which develops immunity using the following process:
The Pfizer-BioNTech vaccine must be stored at ultra-cold temperatures between -112F (-80C) and -76F (-60C) to keep the mRNA molecule in the vaccine stable.
Once diluted and prepared for an injection, it can remain at room temperature for up to 6 hours before it becomes unusable.
You may see the Moderna vaccine called mRNA-1273 in scientific papers. Like the Pfizer-BioNTech vaccine, the Moderna vaccine is given in two doses spaced 28 days (4 weeks) apart.
The Moderna vaccine also uses mRNA technology that uses the same mechanism as the Pfizer-BioNTech vaccine to build immunity to the coronavirus spike protein.
Similar to the Pfizer-BioNTech vaccine, the Moderna vaccine must also be stored at very cold temperatures, between -58F (-50C) and 5F (-15C). Once a vial is opened and prepared for an injection, its stable at room temperature for up to 12 hours.
You may see the Johnson & Johnson (J&J) vaccine referred to as JNJ-78436735 or Ad26.COV2.S in scientific papers. Unlike the Pfizer-BioNTech and Moderna vaccines, the J&J vaccine can be given as a single dose.
The J&J vaccine uses an adenovirus vector, which is a modified inactivated adenovirus (a type of virus) thats designed not to cause disease in people.
Once the vaccine delivers the adenovirus vector into a host cell, the vector is broken down and the adenovirus cannot cause any harm in the body.
Heres how the J&J vaccine works:
Unlike the two mRNA vaccines, the J&J vaccine can be refrigerated rather than frozen because its more stable at higher temperatures. Once a vial is opened and prepared for injection, it can be kept at room temperature for up to 2 hours.
Vaccine efficacy measures the percent reduction of COVID-19 in those who are vaccinated compared with those who have not been vaccinated.
Efficacy is one of the key metrics reported in clinical trials that the FDA reviews when deciding to grant emergency use authorization. Efficacy metrics are also more reliable when a higher number of participants are involved in a clinical trial or study.
Efficacy is measured in a trial or study about 2 weeks after an injection. This is because it takes about 2 weeks to build immunity after receiving one to two doses of any of these three COVID-19 vaccines.
This means youre considered fully vaccinated when its been:
Lets take a look at efficacy data from the large-scale clinical trials for these vaccines.
In the phase 3 clinical trial of the Pfizer-BioNTech vaccine, 43,448 people participated. Each participant received two doses of the vaccine or two doses of a placebo spaced 21 days (3 weeks) apart.
Researchers assessed vaccine efficacy 7 days after the second dose of the vaccine. At this time, it was found that vaccine efficacy was 95 percent.
Heres some other important data from the trial:
In the phase 3 clinical trial of the Moderna vaccine, 30,420 people participated. In this trial, each participant got either two doses of the vaccine or two doses of a placebo spaced 28 days (4 weeks) apart.
Researchers evaluated vaccine efficacy 14 days after the second dose of the vaccine. At this point, vaccine efficacy was found to be 94.1 percent.
Heres some other important data from the trial:
In the phase 3 clinical trial of the J&J vaccine, 39,058 people participated. The trial tested a single dose of the vaccine.
Researchers evaluated vaccine efficacy 14 days after the single dose of the vaccine was given. The results also broke down efficacy by COVID-19 severity and location.
Overall, J&J vaccine efficacy was found to be 66.3 percent. Overall efficacy varied among countries:
J&J vaccine efficacy for severe to critical COVID-19 was:
Heres some other important data from the trial:
COVID-19 vaccines must be proven effective and safe before the FDA can grant emergency use authorization.
The Pfizer-BioNTech, Moderna, and J&J COVID-19 vaccines have met safety and efficacy requirements. Well discuss some possible side effects in more detail later in this article.
People who have had severe allergic reactions to a COVID-19 vaccine or any of its ingredients should not be vaccinated.
Each vaccine manufacturer provides fact sheets with complete lists of vaccine ingredients:
The CDC states that people with an underlying health condition can get vaccinated as long as they havent had a serious allergic reaction to:
This includes people who have a weakened immune system. Specific safety data for people with compromised immune systems is limited. But since these authorized COVID-19 vaccines dont contain live virus, they can be safely given to immunocompromised people.
Vaccination is important for people with underlying health conditions. This is because many types of underlying health conditions can increase the risk of severe COVID-19.
Before getting vaccinated, talk with a healthcare professional and let them know about any underlying health conditions you have or medications youre taking.
The CDC states that people who are pregnant or breastfeeding can receive any of these three authorized COVID-19 vaccines. Theres limited safety data for pregnant and breastfeeding people, but evidence is growing that the vaccines pose minimal risk.
Pregnant people are also at an increased risk of serious illness as well as preterm birth and other pregnancy outcomes due to COVID-19.
If youre pregnant or breastfeeding and are concerned about COVID-19 vaccination, talk with a healthcare professional about:
Each COVID-19 vaccine is associated with side effects.
We dont yet know whether there are long-term side effects to these vaccines. But the CDC notes that long-term health effects are unlikely. These vaccines will be monitored for safety many years after emergency use authorization.
You may experience one or more of the following side effects after receiving the Pfizer-BioNTech vaccine:
These side effects are typically mild to moderate and go away in a few days. Side effects felt throughout the body, like fever and aches and pains, are more commonly reported after the second dose.
More serious side effects include a serious allergic reaction called anaphylaxis, which can include symptoms like:
The Pfizer-BioNTech clinical trial reported only four other serious side effects from the vaccine:
Researchers also reported no deaths due to receiving either the vaccine or the placebo during the trial.
Possible side effects of the Moderna vaccine include:
These side effects are often mild to moderate and go away in a few days. Systemic side effects like fever and aches and pains are more commonly reported after the second dose.
The Moderna vaccine is also associated with delayed pain, swelling, or redness at the injection site, sometimes called COVID arm. The Moderna clinical trial data found that this typically happens 8 or more days after either dose and lasts for 4 to 5 days.
Anaphylaxis has also been reported as a serious side effect of the Moderna vaccine. Clinical trial data also notes that treatment-related severe side effects were higher in the vaccine group than the placebo group.
Seventy-one (0.5 percent) of the 15,185 participants who got the vaccine reported severe side effects, including:
In this clinical trial, two deaths occurred in the vaccine group. One died by suicide, while the other died from cardiac arrest. Investigators could not confirm whether these deaths were related to the vaccine.
Side effects of the J&J vaccine are typically mild to moderate and disappear a few days later. They can include:
Anaphylaxis has also been reported with the J&J vaccine.
The J&J vaccine is also associated with the risk of a very rare blood clot condition called thrombosis with thrombocytopenia syndrome (TTS). TTS was most often observed in females between the ages of 18 and 48.
After a brief pause to review TTS risk, J&J vaccinations resumed in the United States after it was determined that the benefits of the vaccine outweighed this and other risks. The CDC estimates that the risk of TTS is 7 per 1 million for females under age 50.
Other severe side effects observed during the clinical trial of the J&J vaccine only reported by 7 out of the 21,895 participants who received the vaccine, or about 0.03 percent included:
While researchers did observe blood clot events, most were in people with underlying conditions that increase blood clot risk. In total, 11 clotting events were reported in the vaccine group compared with three in the placebo group.
Lastly, the clinical trial of the J&J vaccine reported three deaths in the vaccine group. However, researchers concluded that none of these deaths were related to the vaccine.
Its completely normal for viruses to mutate. These mutations can sometimes harm the virus, making it weaker or less infectious. But new mutations can also provide a virus with an advantage.
So far, many virus variants have been detected for the coronavirus. Some are considered variants of concern because they may be associated with increased transmission or can break through the immune system, even in vaccinated people.
Some reported variants include:
Research into how effective each vaccine is against coronavirus variants is ongoing. Lets discuss what we know so far.
An April 2021 study assessed the Pfizer-BioNTech vaccines activity against variants by using serum from people who had been vaccinated with the Pfizer-BioNTech vaccine. Serum is the part of the blood that contains antibodies.
When this serum was tested against test viruses with spike proteins from different variants, researchers found that Alpha and Gamma test viruses were neutralized at a similar level to the original variant. Neutralization of Beta test viruses was still robust, but lower.
A July 2021 study from Qatar, where most cases of COVID-19 are due to Alpha or Beta, looked at vaccine efficacy in real-world circumstances. Researchers looked at confirmed COVID-19 cases in vaccinated and unvaccinated people.
The vaccine efficacy in people who had been fully vaccinated with the Pfizer-BioNTech vaccine was estimated to be:
Additionally, research from public health officials in the United Kingdom indicates that the Pfizer-BioNTech vaccine is also effective against Alpha and Delta. The vaccines efficacy in fully vaccinated people was:
A July 2021 study found that two doses of the Pfizer-BioNTech vaccine were about 88 percent effective against the Delta variant.
Similar serum studies have also been carried out for the Moderna vaccine.
One study observed that test viruses with spike protein from Alpha were neutralized similarly to the original coronavirus variant. But neutralization was about 6.4 times lower against test viruses with the Beta spike protein.
Another serum study from June 2021 looked at the Moderna vaccines effectiveness against Beta and B.1.429, a variant first detected in California.
Researchers found that the B.1.429 variant was two to three times less sensitive to neutralization, while Beta was 9 to 14 times less sensitive.
The clinical trial of the J&J vaccine was carried out at a different point during the pandemic than the trials for the Pfizer-BioNTech and Moderna vaccines. During the J&J trial, several variants were circulating or common in many parts of the world.
For example, researchers in the trial found that 95 percent of sequenced COVID-19 cases in South Africa were due to the Beta variant. The vaccine efficacy of the J&J vaccine in South Africa was 52 percent overall and 73.1 percent for severe to critical COVID-19.
In Brazil, 69 percent of the sequenced COVID-19 cases were caused by the P.2 lineage at the time of the trial. Here, the efficacy of the J&J vaccine was 66.2 percent overall and 81.9 percent for severe to critical COVID-19.
Overall, the J&J vaccine still appears to be quite effective at reducing the likelihood of developing COVID-19, particularly for severe to critical COVID-19, in locations with variants.
The U.S. federal government is providing all COVID-19 vaccines free of charge during the pandemic, regardless of a persons health insurance or citizenship status.
If you seek a COVID-19 vaccination during this time, you cannot be charged for:
Its unclear whether any of these three authorized vaccines will still be free after the pandemic ends, since all three are produced by for-profit pharmaceutical companies.
But its likely (though not yet confirmed) that youll have to pay for the COVID-19 vaccine after the pandemic is declared over by the World Health Organization (WHO) or other national public health agencies. Potential payment may include both receiving the initial vaccination or a booster shot.
The Pfizer-BioNTech, Moderna, and J&J COVID-19 vaccines are currently authorized in the United States by the FDA under an emergency use authorization (EUA). This is a little bit different than a typical FDA approval.
Simply put, an EUA is a method through which the FDA can allow unapproved medical products to be used during a public health emergency, like a pandemic.
When reviewing a product for an EUA, the FDA must decide that the overall benefits of the product outweigh its potential risks.
Heres what happens during this process:
In addition to the United States, these three COVID-19 vaccines have been authorized or approved in a variety of other countries around the world.
Its important to note that additional authorizations or approvals may occur rapidly.
The Pfizer-BioNTech vaccine was authorized by the FDA on December 11, 2020, for emergency use in people 16 and older. It has since been authorized for use in adolescents between the ages of 12 and 15 as well.
On December 31, 2020, the WHO listed the Pfizer-BioNTech vaccine for emergency use. Since then, many other countries have either authorized or approved the vaccine.
The Moderna vaccine was authorized by the FDA for emergency use in adults 18 and over on December 18, 2020.
Additionally, on April 30, 2021, the WHO listed the Moderna vaccine for emergency use. It has been approved for use in numerous countries worldwide.
The J&J vaccine was authorized by the FDA for emergency use in adults 18 and over on February 27, 2021.
It was listed by the WHO for emergency use on March 12, 2021. Many other countries have also authorized or approved the J&J vaccine.
Now, lets briefly discuss each company that produced the vaccine.
Pfizer is an American pharmaceutical company headquartered in New York City. Its mission is to develop drugs and vaccines that can help improve health and wellness.
Some of Pfizers more well-known products include:
Original post:
All About the Moderna, Pfizer, and Johnson & Johnson Vaccines - Healthline
- As 2024 Travel Hits Pre-Covid Levels, Here's When To Go To Europe - Forbes - March 10th, 2024 [March 10th, 2024]
- Comparison of Impressions of COVID-19 Vaccinations Stratified by the Number of Vaccinations Among Japanese ... - Cureus - March 10th, 2024 [March 10th, 2024]
- Effect of the COVID-19 pandemic on mental health visits in primary care: an interrupted time series analysis from nine ... - The Lancet - March 10th, 2024 [March 10th, 2024]
- Faith and rehab keep Southwick woman on path to recovery from COVID - MassLive.com - March 10th, 2024 [March 10th, 2024]
- China to draw on Covid-19 experience to tackle future pandemics - theSun - March 10th, 2024 [March 10th, 2024]
- Free COVID tests through USPS are ending todayhere's where to get tests online - Reviewed - March 10th, 2024 [March 10th, 2024]
- Concern about COVID reaches record low across political spectrum: Survey - The Hill - March 10th, 2024 [March 10th, 2024]
- He Had 217 Covid Shots Without Side Effects, Study Finds - The New York Times - March 10th, 2024 [March 10th, 2024]
- A Man Got 217 COVID-19 Vaccines. Here's What Happened - TIME - March 10th, 2024 [March 10th, 2024]
- German man vaccinated 217 times against covid with no ill effects - The Washington Post - March 10th, 2024 [March 10th, 2024]
- Andrew Cuomo Faces House Subpoena Over Covid Deaths in Nursing Homes - The New York Times - March 10th, 2024 [March 10th, 2024]
- It's been 4 years since COVID hit Michigan. For Long COVID patients, the pandemic isn't over. Michigan Advance - Michigan Advance - March 10th, 2024 [March 10th, 2024]
- 4th Anniversary of the Covid-19 Pandemic - erienewsnow.com - March 10th, 2024 [March 10th, 2024]
- Reflecting on 4 years of the COVID-19 pandemic and discussing what's to come - WBUR News - March 10th, 2024 [March 10th, 2024]
- CDC shortens 5-day COVID isolation, updates guidance on masks and testing in new 2024 recommendations - CBS News - March 10th, 2024 [March 10th, 2024]
- Father, daughter convicted in fraud related to COVID-19 relief - The Cincinnati Enquirer - February 7th, 2024 [February 7th, 2024]
- Supreme Court to weigh whether Covid misinformation is protected speech - STAT - February 7th, 2024 [February 7th, 2024]
- Oklahoma leads country in long Covid - 2 News Oklahoma KJRH Tulsa - February 7th, 2024 [February 7th, 2024]
- MCFR firefighter dies after battle with COVID-19 - WCJB - February 7th, 2024 [February 7th, 2024]
- Audio-based AI classifiers show no evidence of improved COVID-19 screening over simple symptoms checkers - Nature.com - February 7th, 2024 [February 7th, 2024]
- Hidden death toll of COVID-19 pandemic revealed - Earth.com - February 7th, 2024 [February 7th, 2024]
- Switching arms improves effectiveness of two-dose vaccinations, OHSU study suggests - OHSU News - February 7th, 2024 [February 7th, 2024]
- Tributes paid to Irish health official 'central' to EU Covid-19 response - The Irish Times - February 7th, 2024 [February 7th, 2024]
- Court: Not wearing mask during COVID-19 health emergency isn't protected speech - Honolulu Star-Advertiser - February 7th, 2024 [February 7th, 2024]
- One arm or two? How you get vaccinated may make a difference - The Seattle Times - February 7th, 2024 [February 7th, 2024]
- 70% of kindergarteners didn't pass readiness test in pandemic, study estimates - University of Minnesota Twin Cities - February 7th, 2024 [February 7th, 2024]
- USS Theodore Roosevelt sailors roam free on Guam for first time since COVID-19 outbreak - Stars and Stripes - February 7th, 2024 [February 7th, 2024]
- Pandemic linked to 14% increase in underweight children in India - Medical Xpress - February 7th, 2024 [February 7th, 2024]
- COVID and travel: Should I still wear a mask on the plane? - USA TODAY - February 7th, 2024 [February 7th, 2024]
- Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in ... - Globalization and Health - February 7th, 2024 [February 7th, 2024]
- Increase in STIs Among Adolescents Witnessed During COVID-19 Pandemic - Drug Topics - February 7th, 2024 [February 7th, 2024]
- VDH: COVID deaths not seeing decline - Vermont Biz - February 7th, 2024 [February 7th, 2024]
- US outpatient care for serious mental health issues declined during COVID-19 - University of Minnesota Twin Cities - February 7th, 2024 [February 7th, 2024]
- COVID-19 Vaccination in a Patient With Gluten Enteropathy: A Case Report - Cureus - February 7th, 2024 [February 7th, 2024]
- COVID-19 cases drop, but still lots of flu, RSV cases in Erie County - GoErie.com - February 7th, 2024 [February 7th, 2024]
- Lives versus livelihoods: The COVID-19 trade-off from an epidemiological-economic perspective - CEPR - February 7th, 2024 [February 7th, 2024]
- Weatherhead's Jonathan Ernest notes economic changes of childcare facilities following COVID-19 pandemic - The Daily | Case Western Reserve University - February 7th, 2024 [February 7th, 2024]
- U.S. adults face distress, unequal mental health care access during the COVID-19 era - News-Medical.Net - February 7th, 2024 [February 7th, 2024]
- Simnotrelvir to reduces the symptoms of mild to moderate COVID-19 - 2 Minute Medicine - February 7th, 2024 [February 7th, 2024]
- Vaccine Effectiveness: Which COVID-19 Shots Offer the Most Protection? - SciTechDaily - February 7th, 2024 [February 7th, 2024]
- New evidence confirms COVID-19 vaccination in pregnancy is safe for babies - Gavi, the Vaccine Alliance - February 7th, 2024 [February 7th, 2024]
- Audit Committee co-chairs, Evers at odds over interest from COVID-19 funds - WisPolitics.com - February 7th, 2024 [February 7th, 2024]
- Evaluation of Olfactory Dysfunction Among COVID-19 Patients in Baghdad, Iraq - Cureus - February 7th, 2024 [February 7th, 2024]
- COVID-19's impact on early education: Retrospective study shows decrease in kindergarten readiness - News-Medical.Net - February 7th, 2024 [February 7th, 2024]
- Rutgers researchers work on breakthrough COVID-19 treatment | Video - NJ Spotlight News - February 7th, 2024 [February 7th, 2024]
- Curious Iowa: Has the state spent all of its COVID-19 relief funding? - The Gazette - October 16th, 2023 [October 16th, 2023]
- Accelerating into Immunization Agenda 2030 with momentum from ... - Infectious Diseases of Poverty - BioMed Central - October 16th, 2023 [October 16th, 2023]
- Study Uncovers Why Young Children Suffer Less Severe COVID-19 - Technology Networks - October 16th, 2023 [October 16th, 2023]
- Wenstrup, Select Subcommittee Majority Members Investigate ... - House Committee on Oversight and Reform | - October 16th, 2023 [October 16th, 2023]
- With COVID-19 emergency orders lifted, employers seek guidance ... - Hartford Business Journal - October 16th, 2023 [October 16th, 2023]
- Computer-aided diagnosis of chest X-ray for COVID-19 diagnosis in ... - Nature.com - October 16th, 2023 [October 16th, 2023]
- Maternal COVID-19 Vaccination, Infection Boosts Infant Antibody ... - Contagionlive.com - October 16th, 2023 [October 16th, 2023]
- Three Middlesex County Individuals Admit COVID-19 Fraud ... - Department of Justice - October 16th, 2023 [October 16th, 2023]
- Seventeen Broward Sheriff's Office Employees Charged with COVID ... - Department of Justice - October 16th, 2023 [October 16th, 2023]
- New COVID-19 Booster and Flu Shot Available at Select Public ... - Mecklenburg County (.gov) - October 16th, 2023 [October 16th, 2023]
- Ban on COVID vaccine mandates by private businesses, including ... - The Texas Tribune - October 16th, 2023 [October 16th, 2023]
- What Are the Side Effects of the 2023 COVID Vaccine? Experts ... - Good Housekeeping - October 16th, 2023 [October 16th, 2023]
- Covid inquiry: Bereaved families relief as High Court dismisses Cabinet Office JR - openDemocracy - July 6th, 2023 [July 6th, 2023]
- UK health agency failed to account for 3.3bn of Covid inventory, say MPs - Financial Times - July 6th, 2023 [July 6th, 2023]
- COVID-19 Working Paper: Obesity Prevalence Among U.S. Adult ... - usda.gov - July 6th, 2023 [July 6th, 2023]
- California Changes Definition of COVID-19 Outbreak Easing the ... - Fisher Phillips - July 6th, 2023 [July 6th, 2023]
- New Study Shows Robust Pandemic Preparedness Strongly Linked ... - Nuclear Threat Initiative - July 6th, 2023 [July 6th, 2023]
- COVID-19 Infection Reduces the Risk of UTIs, Bacteremia, and ... - Contagionlive.com - July 6th, 2023 [July 6th, 2023]
- Europe Phases Out COVID-19 Flexible Regulations - Pharmaceutical Technology Magazine - July 6th, 2023 [July 6th, 2023]
- Travel Pains and COVID: How to Decide if You're Ready to Travel - CreakyJoints - July 6th, 2023 [July 6th, 2023]
- COVID Depression and Anxiety | Johns Hopkins Medicine - April 17th, 2023 [April 17th, 2023]
- Man declared dead due to Covid found 'shockingly' alive after 2 years in MP - Hindustan Times - April 17th, 2023 [April 17th, 2023]
- Senate votes to end Covid-19 emergency, 3 years after initial declaration - CNN - March 31st, 2023 [March 31st, 2023]
- DC COVID-19 centers closing Friday: Here's what you need to know - WJLA - March 31st, 2023 [March 31st, 2023]
- Can grade retention help with COVID-19 learning recovery in schools? - Brookings Institution - March 28th, 2023 [March 28th, 2023]
- On 3-year anniversary of COVID-19 in NC, Winston-Salem woman shares story of loss and healing after losing 2 loved ones - WXII12 Winston-Salem - March 4th, 2023 [March 4th, 2023]
- Oregon, Washington will lift mask requirements in health care settings on April 3 - KATU - March 4th, 2023 [March 4th, 2023]
- WHO says all theories for COVID origin 'remain on table' as lab leak theory gains traction - Sky News - March 4th, 2023 [March 4th, 2023]
- New COVID-19 omicron subvariant XBB.1.5 sweeping the nation, making up majority of cases - ABC Action News Tampa Bay - February 15th, 2023 [February 15th, 2023]
- Man gets 21 years in prison for stabbing wife in the Ozarks over COVID-19 stimulus check and their children - Law & Crime - February 15th, 2023 [February 15th, 2023]
- Healthline: Medical information and health advice you can trust. - January 2nd, 2023 [January 2nd, 2023]
- China can expect repeat Covid infections with new strains on the way: experts - South China Morning Post - January 2nd, 2023 [January 2nd, 2023]
- PCR tests for travellers reintroduced around the world as Covid-19 cases surge - The National - January 2nd, 2023 [January 2nd, 2023]
- Covid-19 surge after Covid-19 surge has made it impossible for US hospitals to plan for the future - Vox.com - January 2nd, 2023 [January 2nd, 2023]
- COVID-19 in China: Demand for a particular fruit rises as people seek natural remedies to fight the virus - WION - December 21st, 2022 [December 21st, 2022]